VCP and Miyoshi myopathy: Notably, MM patients with high VCP expression suffered from poor clinical outcomes relative to low-VCP-expressing patients in TT2 cohort, which was presented as shorter response duration of overall survival (OS) (n = 351, *p = 0.0456) (Figure 1B).